Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 2/2022

17-07-2021 | Review

The impact of acute pneumococcal disease on health state utility values: a systematic review

Auteurs: Ryan O’Reilly, Sayako Yokoyama, Justin Boyle, Jeffrey C. Kwong, Allison McGeer, Teresa To, Beate Sander

Gepubliceerd in: Quality of Life Research | Uitgave 2/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Streptococcus pneumoniae infections remain a significant source of morbidity and mortality worldwide. The purpose of this review was to summarize the impact of pneumococcal disease on health state utilities (HSU) in the acute phase of illness.

Methods

We searched MEDLINE, EMBASE, EconLit, the Health Technology Assessment Database, the National Health Economic Evaluation Database, and Tufts Cost-Effectiveness Registry (up to January 2020) for primary studies. Eligible studies elicited HSU estimates using preference-based instruments for the acute phase of infection of pneumococcal syndromes including acute otitis media, pneumonia/lower respiratory tract infections, bacteremia/sepsis, and meningitis. Two reviewers independently conducted screening, data extraction and quality appraisal.

Results

We screened 10,178 studies, of which 26 met our inclusion criteria. Cohort sizes ranged from 8 to 2060 respondents. The most frequently studied syndrome was pneumonia (n = 17), followed by acute otitis media (n = 9), meningitis (n = 7) and bacteremia/sepsis (n = 4). Overall, each syndrome was associated with a substantial impact on HSU. Bacteremia/sepsis (range: − 0.331 to 0.992) and meningitis (range: − 0.330 to 0.977) were generally associated with the lowest HSU, followed by pneumonia (range: − 0.054 to 0.998) and acute otitis media (range: 0.064 to 0.970). HSU estimates varied considerably by treatment setting, elicitation method and type of respondent. The only study to compare pneumococcal infections to non-pneumococcal infections in the same population revealed significantly lower HSU estimates among pneumococcal infections.

Conclusions

Pneumococcal syndromes are associated with decreased HSU estimates. Given the considerable heterogeneity in methods and source populations as well as study quality, care should be taken to select the most appropriate estimates.
vorige artikel Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation
volgende artikel Patient-reported outcomes, sociodemographic and clinical factors are associated with 1-year mortality in patients with ischemic heart disease—findings from the DenHeart cohort study
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Mehr, S., & Wood, N. (2012). Streptococcus pneumonia—a review of carriage, infection, serotype replacement and vaccination. Paediatric Respiratory Reviews, 13(4), 258–264.PubMed
2.
Deng, X., Church, D., Vanderkooi, O. G., Low, D. E., & Pillai, D. R. (2013). Streptococcus pneumoniae infection: A Canadian perspective. Expert Review of Anti-infective Therapy, 11(8), 781–791.PubMed
3.
Wahl, B., O’Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukšić, I., Nair, H., McAllister, D. A., Campbell, H., Rudan, I., Black, R., & Knoll, M. D. (2018). Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000–15. The Lancet Global Health, 6(7), e744–e757.PubMedPubMedCentral
4.
Weycker, D., Farkouh, R. A., Strutton, D. R., Edelsberg, J., Shea, K. M., & Pelton, S. I. (2016). Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Services Research, 16(1), 182.PubMedPubMedCentral
5.
Neumann, P. J., Sanders, G. D., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Cost-effectiveness in health and medicine. Oxford University Press.
6.
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. Oxford University Press.
7.
Culyer, A. J. (2014). Encyclopedia of health economics (1st ed.). Elsevier.
8.
Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96(1), 5–21.PubMed
9.
Detsky, A. S., & Laupacis, A. (2007). Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA, 298(2), 221–224.PubMed
10.
Parkin, D., & Devlin, N. (2006). Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Economics, 15(7), 653–664.PubMed
11.
Brouwer, C. N., Maillé, A. R., Rovers, M. M., Grobbee, D. E., Sanders, E. A., & Schilder, A. G. (2005). Health-related quality of life in children with otitis media. International Journal of Pediatric Otorhinolaryngology, 69(8), 1031–1041.PubMed
12.
Winters, B. D., Eberlein, M., Leung, J., Needham, D. M., Pronovost, P. J., & Sevransky, J. E. (2010). Long-term mortality and quality of life in sepsis: A systematic review. Critical Care Medicine, 38(5), 1276–1283.PubMed
13.
Jacob, C., Mittendorf, T., & von der Schulenburg Graf, J. (2011). Costs of illness and health-related quality of life for community-acquired pneumonia—a systematic review. Pneumologie (Stuttgart, Germany), 65(8), 498–502.
14.
Dirmesropian, S., Wood, J., MacIntyre, C., & Newall, A. (2015). A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly. Human Vaccines & Immunotherapeutics, 11(4), 818–825.
15.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.PubMed
16.
Haddaway, N. R., Collins, A. M., Coughlin, D., & Kirk, S. (2015). The role of Google Scholar in evidence reviews and its applicability to grey literature searching. PLoS ONE, 10(9), e0138237.PubMedPubMedCentral
17.
Papaioannou, D., Brazier, J., & Paisley, S. (2013). Systematic searching and selection of health state utility values from the literature. Value in Health, 16(4), 686–695.PubMed
18.
Glanville, J. F. K., Yellowlees, A., Kaunelis, D., & Mensinkai, S. (2009). Development and testing of search filters to identify economic evaluations in MEDLINE and EMBASE. Canadian Agency for Drugs and Technologies in Health.
19.
Edmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010). Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis. The Lancet Infectious Diseases, 10(5), 317–328.PubMed
20.
21.
Zhang, Y., Alonso-Coello, P., Guyatt, G. H., Yepes-Nuñez, J. J., Akl, E. A., Hazlewood, G., Pardo-Hernandez, H., Etxeandia-Ikobaltzeta, I., Qaseem, A., Williams, J. W., Jr., Tugwell, P., Flottorp, S., Chang, Y., Zhang, Y., Mustafa, R. A., Rojas, M. X., & Schünemann, H. J. (2019). GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences—risk of bias and indirectness. Journal of Clinical Epidemiology, 111, 94–104.PubMed
22.
23.
Peasgood, T., & Brazier, J. (2015). Is meta-analysis for utility values appropriate given the potential impact different elicitation methods have on values? PharmacoEconomics, 33(11), 1101–1105.PubMedPubMedCentral
24.
Crawford, B., Hashim, S. S., Prepageran, N., See, G. B., Meier, G., Wada, K., Coon, C., Delgleize, E., & DeRosa, M. (2017). Impact of pediatric acute otitis media on child and parental quality of life and associated productivity loss in Malaysia: A prospective observational study. Drugs Real World Outcomes, 4(1), 21. https://​doi.​org/​10.​1007/​s40801-016-0099-9CrossRefPubMed
25.
Kujala, T., Alho, O.-P., Kristo, A., Uhari, M., Renko, M., Pokka, T., & Koivunen, P. (2014). Quality of life after surgery for recurrent otitis media in a randomized controlled trial. The Pediatric Infectious Disease Journal, 33(7), 715–719.PubMed
26.
Heidemann, C. H., Godballe, C., Kjeldsen, A. D., Johansen, E. C. J., Faber, C. E., & Lauridsen, H. H. (2013). The Otitis Media-6 questionnaire: Psychometric properties with emphasis on factor structure and interpretability. Health and Quality of Life Outcomes, 11(1), 201.PubMedPubMedCentral
27.
Kulpeng, W., Sornsrivichai, V., Chongsuvivatwong, V., Rattanavipapong, W., Leelahavarong, P., Cairns, J., Lubell, Y., & Teerawattananon, Y. (2013). Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. BMC Pediatrics, 13(1), 122.PubMedPubMedCentral
28.
Brouwer, C. N., Maillé, A. R., Rovers, M. M., Veenhoven, R. H., Grobbee, D. E., Sanders, E. A., & Schilder, A. G. (2005). Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: A randomized, controlled trial. Pediatrics, 115(2), 273–279.PubMed
29.
Galante, J., Augustovski, F., Colantonio, L., Bardach, A., Caporale, J., Marti, S. G., & Kind, P. (2011). Estimation and comparison of EQ-5D health states’ utility weights for pneumoccocal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in Health, 14(5), S60–S64.PubMed
30.
Carroll, A. E., & Downs, S. M. (2009). Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. The Journal of Pediatrics, 155(1), 21-25.e25.PubMed
31.
Lawrence, R. S., Durch, J. S., & Stratton, K. R. (2001). Vaccines for the 21st century: A tool for decisionmaking. National Academies Press.
32.
Oh, P. I., Maerov, P., Pritchard, D., Knowles, S. R., Einarson, T. R., & Shear, N. H. (1996). A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clinical Therapeutics, 18(1), 160–182.PubMed
33.
Clausen, L. N., Børgesen, M., Ravn, P., & Møller, T. (2019). Fast-track pneumonia pathway focusing on early progressive mobilisation: A clinical feasibility study. ERJ Open Research, 5(1), 00012–02019.PubMedPubMedCentral
34.
35.
Zornić, N., Milovanović, D., Stojadinović, M., Radovanović, D., Davidović, G., Simović, S., Bukumirić, Z., Janjić, V., Marić, N., Jevdjić, J., & Rosić, V. (2018). Quality of life of the mechanically ventilated patients with community-acquired pneumonia. Vojnosanitetski pregled, 75(9), 864–874.
36.
37.
Oppong, R., Smith, R. D., Little, P., Verheij, T., Butler, C. C., Goossens, H., Coenen, S., Moore, M., & Coast, J. (2016). Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: An economic evaluation accounting for the cost of antimicrobial resistance. British Journal of General Practice, 66(650), e633–e639.
38.
Flamaing, J., De Backer, W., Van Laethem, Y., Heijmans, S., & Mignon, A. (2015). Pneumococcal lower respiratory tract infections in adults: An observational case-control study in primary care in Belgium. BMC Family Practice, 16(1), 66.PubMedPubMedCentral
39.
Oppong, R., Jit, M., Smith, R. D., Butler, C. C., Melbye, H., Mölstad, S., & Coast, J. (2013a). Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. British Journal of General Practice, 63(612), e465–e471.
40.
Oppong, R., Kaambwa, B., Nuttall, J., Hood, K., Smith, R. D., & Coast, J. (2013b). The impact of using different tariffs to value EQ-5D health state descriptions: An example from a study of acute cough/lower respiratory tract infections in seven countries. The European Journal of Health Economics, 14(2), 197–209.PubMed
41.
Goldfeld, K. S., Hamel, M. B., & Mitchell, S. L. (2012). Mapping health status measures to a utility measure in a study of nursing home residents with advanced dementia. Medical Care, 50(5), 446.PubMedPubMedCentral
42.
Schuetz, P., Albrich, W. C., Suter, I., Hug, B. L., Christ-Crain, M., Holler, T., Henzen, C., Krause, M., Schoenenberger, R., Zimmerli, W., & Mueller, B. (2011). Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia. Swiss Medical Weekly, 141, w13228.PubMed
43.
Lee, G. M., Salomon, J. A., LeBaron, C. W., & Lieu, T. A. (2005). Health-state valuations for pertussis: Methods for valuing short-term health states. Health and Quality of Life Outcomes, 3(1), 17.PubMedPubMedCentral
44.
Stouthard, M. E., Essink-Bot, M. L., Bonsel, G. J., Barendregt, J. J., Kramers, P. G., Van de Water, H. P., Gunning-Schepers, L. J., & van der Maas, P. J. (1997). Disability weights for diseases in the Netherlands. Inst. Sociale Geneeskunde.
45.
Coley, C. M., Li, Y. H., Medsger, A. R., Marrie, T. J., Fine, M. J., Kapoor, W. N., Lave, J. R., Detsky, A. S., Weinstein, M. C., & Singer, D. E. (1996). Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Archives of Internal Medicine, 156(14), 1565–1571.PubMed
46.
Kramer, M. S., Etezadi-Amoli, J., Ciampi, A., Tange, S. M., Drummond, K. N., Mills, E. L., Bernstein, M. L., & Leduc, D. G. (1994). Parents’ versus physicians’ values for clinical outcomes in young febrile children. Pediatrics, 93(5), 697–702.PubMed
47.
Bennett, J. E., Sumner, W., Downs, S. M., & Jaffe, D. M. (2000). Parents’ utilities for outcomes of occult bacteremia. Archives of Pediatrics & Adolescent Medicine, 154(1), 43–48.
48.
McGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., Jung, A., Adan, G., Gummery, A., Sulaiman, W. A. W., Ennis, K., Martin, A. P., Haycox, A., Miller, A., Solomon, T., & UK Meningitis Study Investigators. (2018). Incidence, aetiology, and sequelae of viral meningitis in UK adults: A multicentre prospective observational cohort study. The Lancet Infectious Diseases, 18(9), 992. https://​doi.​org/​10.​1016/​S1473-3099%2818%2930245-7CrossRefPubMedPubMedCentral
49.
Petrou, S., & Kupek, E. (2009). Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland. Medical Decision Making, 29(3), 291–303.PubMed
50.
Brazier, J., Ara, R., Azzabi, I., Busschbach, J., Chevrou-Séverac, H., Crawford, B., Cruz, L., Karnon, J., Lloyd, A., Paisley, S., & Pickard, A. S. (2019). Identification, review, and use of health state utilities in cost-effectiveness models: An ISPOR good practices for outcomes research task force report. Value in Health, 22(3), 267–275.PubMed
51.
Han, R., François, C., & Toumi, M. (2020). Systematic review of health state utility values used in European pharmacoeconomic evaluations for chronic hepatitis C: Impact on cost-effectiveness results. Applied Health Economics and Health Policy, 19, 1–16.
52.
Arnold, D., Girling, A., Stevens, A., & Lilford, R. (2009). Comparison of direct and indirect methods of estimating health state utilities for resource allocation: Review and empirical analysis. BMJ, 339, b2688.PubMedPubMedCentral
53.
Dobrez, D. G., & Calhoun, E. A. (2004). Testing subject comprehension of utility questionnaires. Quality of Life Research, 13(2), 369–376.PubMed
54.
Woloshin, S., Schwartz, L. M., Moncur, M., Gabriel, S., & Tosteson, A. N. (2001). Assessing values for health: Numeracy matters. Medical Decision Making, 21(5), 382–390.PubMed
55.
Shiri, T., Khan, K., Keaney, K., Mukherjee, G., McCarthy, N. D., & Petrou, S. (2019). Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions. Value in Health., 22(11), 1329–1344.PubMed
56.
Honselmann, K. C., Buthut, F., Heuwer, B., Karadag, S., Sayk, F., Kurowski, V., Thiele, H., Droemann, D., & Wolfrum, S. (2015). Long-term mortality and quality of life in intensive care patients treated for pneumonia and/or sepsis: Predictors of mortality and quality of life in patients with sepsis/pneumonia. Journal of Critical Care, 30(4), 721–726.PubMed
57.
Higgins, A. M., Peake, S. L., Bellomo, R., Cooper, D. J., Delaney, A., Harris, A. H., Howe, B. D., Nichol, A. D., Webb, S. A., Williams, P. J., & Australasian Resuscitation in Sepsis Evaluation (ARISE) Investigators and the ANZICS Clinical Trials Group. (2019). Quality of life and 1-year survival in patients with early septic shock: Long-term follow-up of the Australasian resuscitation in sepsis evaluation trial. Critical Care Medicine, 47(6), 765. https://​doi.​org/​10.​1097/​CCM.​0000000000003762​CrossRefPubMed
58.
Legood, R., Coen, P. G., Knox, K., Viner, R. M., El Bashir, H., Christie, D., Patel, B. C., & Booy, R. (2009). Health related quality of life in survivors of pneumococcal meningitis. Acta Paediatrica, 98(3), 543–547.PubMed
Metagegevens
Titel
The impact of acute pneumococcal disease on health state utility values: a systematic review
Auteurs
Ryan O’Reilly
Sayako Yokoyama
Justin Boyle
Jeffrey C. Kwong
Allison McGeer
Teresa To
Beate Sander
Publicatiedatum
17-07-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02941-y

Andere artikelen Uitgave 2/2022

Quality of Life Research 2/2022 Naar de uitgave

Review

Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation

OriginalPaper

Norwegian population norms for the EQ-5D-5L: results from a general population survey

OriginalPaper

Does depression in multiple sclerosis mediate effects of cognitive functioning on quality of life?

OriginalPaper

Psychometric examination of short forms from the University of Washington pain-related self-efficacy and concerns about pain item banks in patients with low back pain

OriginalPaper

Feasibility and performance of smartphone-based daily micro-surveys among patients recovering from cancer surgery

OriginalPaper

Predicting presenteeism using measures of health status